CinCor Pharma Inc. Recorded Big Gain
CinCor Pharma Inc. (CINC:NASDAQ) jumped higher at $28.74, representing a gain of 144%. On Mon, Jan 09, 2023, CINC:NASDAQ hit a New 2-Week High of $28.74. The stock appeared on our News Catalysts scanner on Mon, Jan 09, 2023 at 02:29 PM in the 'BIOTECH' category. From Tue, Dec 27, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days
The stock spiked on Mon, Aug 08, 2022 at $43.15 with a volume of 2M+.
About CinCor Pharma Inc. (CINC:NASDAQ)
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Top 10 Gainers:
- CinCor Pharma Inc. (CINC:NASDAQ), 143.97%
- Amryt Pharma plc (AMYT:NASDAQ), 106.99%
- Albireo Pharma, Inc. (ALBO:NASDAQ), 92.16%
- Apexigen Inc Com (APGN:NASDAQ), 91.49%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 54.34%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 52.86%
- Duck Creek Technologies Inc. (DCT:NASDAQ), 46.5%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.39%
- Ebang International Holdings Inc. (EBON:NASDAQ), 40.72%
- Greenidge Generation Holdings Inc. (GREE:NASDAQ), 37.9%